Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy
A clinical trial evaluating whether Veristrat, a biomarker test, can predict which patients with non-small cell lung cancer will benefit fro…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma [NA]
This document reports a clinical trial update testing metformin in combination with a tyrosine kinase inhibitor for Non-Small Cell Lung Canc…
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.
This completed French survey assesses how elderly patients with histologically or cytologically confirmed non-small cell lung cancer are dia…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR) [Phase 3]
Phase 3 clinical trial evaluating apatinib as a third- or fourth-line treatment for advanced non-squamous non-small cell lung cancer with wi…
-
CLINICAL_TRIALS research · 2017-02-20Clinical Trial Update: The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells [Phase 1]
Phase 1 clinical trial evaluating Dribbles antigen to activate T cells for advanced non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-17Clinical Trial Update: Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial is evaluating the combination of apatinib mesylate and pemetrexed in patients with pretreated advanced non-squamous non-smal…
-
CLINICAL_TRIALS research · 2017-02-15Clinical Trial Update: Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients [Phase 2]
A Phase 2 clinical trial update on adjuvant pembrolizumab for N2-positive stage IIIA non-small cell lung cancer; the current status of the t…
-
CLINICAL_TRIALS research · 2017-02-15Clinical Trial Update: Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction [NA]
This document is a clinical trial update evaluating MR-PET imaging for diagnosis, treatment outcomes, and prognosis prediction in non-small …
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial updating Apatinib in combination with EGFR-TKI for advanced EGFR-TKI-resistant non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment [Phase 2]
A Phase 2 clinical trial exploring the combined use of natural killer cell therapy with doublet chemotherapy as first-line treatment for adv…
-
CLINICAL_TRIALS research · 2017-01-31Clinical Trial Update: Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer [EARLY_Phase 1]
This clinical trial update describes a Phase 1 study combining stereotactic radiosurgery with systemic dose chemotherapy for locally advance…
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology [Phase 1, Phase 2]
A terminated Phase 1/2 study evaluating RO5479599 in combination with carboplatin and paclitaxel for advanced or metastatic squamous non-sma…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients
This clinical trial update discusses how osimertinib treatment in advanced non-small cell lung cancer influences PD-L1 and other immuno-mark…
-
CLINICAL_TRIALS research · 2017-01-20Clinical Trial Update: EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
This clinical trial update describes observations on resistance patterns to EGFR tyrosine kinase inhibitors in Chinese patients with advance…
-
CLINICAL_TRIALS research · 2017-01-19Clinical Trial Update: Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors
This clinical trial update discusses research on predicting resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-01-06Clinical Trial Update: Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer
An update on a clinical trial characterizing peripheral muscle function in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-01-06Clinical Trial Update: Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGS [NA]
Clinical trial investigating gene mutation differences in matched samples from patients with advanced non-small cell lung cancer using next-…
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC [Phase 3]
This document describes an ongoing Phase 3 clinical trial evaluating Endostar in combination with an EGFR-TKI for EGFR mutation-positive non…
-
CLINICAL_TRIALS research · 2017-01-02Clinical Trial Update: Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type [Phase 2]
A phase 2 clinical trial evaluating YQ1 plus cisplatin-based chemotherapy in advanced non-small cell lung cancer with EGFR wild-type status.…
-
CLINICAL_TRIALS research · 2016-12-28Clinical Trial Update: EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism [Phase 2]
This Phase 2 trial is evaluating whether adding chemotherapy to an EGFR tyrosine kinase inhibitor improves outcomes in non-small cell lung c…
-
CLINICAL_TRIALS research · 2016-12-20Clinical Trial Update: Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered
Clinical trial update describing complete endosonographic intrathoracic nodal staging for NSCLC patients considered for SABR; current trial …
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2, Phase 3]
This document outlines a Phase II/III trial of Anlotinib in advanced non-small cell lung cancer, focusing on predicting efficacy by measurin…
-
CLINICAL_TRIALS research · 2016-12-15Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in patients with stage III/IV or relapsed non-small cell lung cancer who received first-…
-
CLINICAL_TRIALS research · 2016-12-14Clinical Trial Update: Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer [NA]
This clinical trial compares single-port, two-port, and three-port video-assisted thoracoscopic surgery (VATS) for non-small cell lung cance…
-
CLINICAL_TRIALS research · 2016-12-14Clinical Trial Update: Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
This clinical trial investigates the relationship between EGFR mutations detected in circulating cell-free DNA and circulating tumor cells i…